125 related articles for article (PubMed ID: 34664502)
1. Mechanism-Based Inactivation of
Mellott DM; Torres D; Krieger IV; Cameron SA; Moghadamchargari Z; Laganowsky A; Sacchettini JC; Meek TD; Harris LD
J Am Chem Soc; 2021 Oct; 143(42):17666-17676. PubMed ID: 34664502
[TBL] [Abstract][Full Text] [Related]
2. Covalent Inactivation of
Pham TV; Mellott DM; Moghadamchargari Z; Chen K; Krieger I; Laganowsky A; Sacchettini JC; Meek TD
ACS Chem Biol; 2021 Mar; 16(3):463-470. PubMed ID: 33688722
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
[TBL] [Abstract][Full Text] [Related]
4. The Nitro Group as a Masked Electrophile in Covalent Enzyme Inhibition.
Ray S; Kreitler DF; Gulick AM; Murkin AS
ACS Chem Biol; 2018 Jun; 13(6):1470-1473. PubMed ID: 29782144
[TBL] [Abstract][Full Text] [Related]
5. Cysteine is the general base that serves in catalysis by isocitrate lyase and in mechanism-based inhibition by 3-nitropropionate.
Moynihan MM; Murkin AS
Biochemistry; 2014 Jan; 53(1):178-87. PubMed ID: 24354272
[TBL] [Abstract][Full Text] [Related]
6. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
Muñoz-Elías EJ; McKinney JD
Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
[TBL] [Abstract][Full Text] [Related]
8. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Quartararo CE; Hadi T; Cahill SM; Blanchard JS
Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
Kwon S; Chun HL; Ha HJ; Lee SY; Park HH
PLoS One; 2021; 16(5):e0251067. PubMed ID: 33951112
[TBL] [Abstract][Full Text] [Related]
10. Advances in mycobacterial isocitrate lyase targeting and inhibitors.
Krátký M; Vinšová J
Curr Med Chem; 2012; 19(36):6126-37. PubMed ID: 23092127
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
[TBL] [Abstract][Full Text] [Related]
12. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.
Gould TA; van de Langemheen H; Muñoz-Elías EJ; McKinney JD; Sacchettini JC
Mol Microbiol; 2006 Aug; 61(4):940-7. PubMed ID: 16879647
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of isocitrate lyase by 3-nitropropionate, a reaction-intermediate analogue.
Schloss JV; Cleland WW
Biochemistry; 1982 Aug; 21(18):4420-7. PubMed ID: 7126549
[No Abstract] [Full Text] [Related]
14. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the
Ko EM; Kim JY; Lee S; Kim S; Hwang J; Oh JI
J Bacteriol; 2021 Nov; 203(23):e0040221. PubMed ID: 34516281
[TBL] [Abstract][Full Text] [Related]
16. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
18. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
[TBL] [Abstract][Full Text] [Related]
19. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
[TBL] [Abstract][Full Text] [Related]
20. Microbiology. A weak link in TB bacterium is found.
Helmuth L
Science; 2000 Aug; 289(5482):1123-5. PubMed ID: 10970221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
